Provider notes

• NMUH:
• Non-formulary
• RFL:
• Renal transplant: For transplant induction and rejection
• Liver transplant: For transplant rejection only
• RNOH:
• Non-formulary
• UCLH:
• WH:
• Non-formulary

See NICE TA for eligibility criteria

Provider notes

• NMUH:
  • This medicine has a positive NICE Technology Appraisal but service is not offered at NMUH.
  • Check MHRA Drug Safety Alerts
• RFL:
  • Prior funding required for treatment of lymphoma with radiolabelled basiliximab.
  • Approved for Renal (as per TA) and Liver (contact Pharmacy) for transplant patients.
• RNOH:
  • Non-formulary
• UCLH:
• WH:
  • Non-formulary

 (hospital only prescribing) for renal transplant

for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

Provider notes

• NMUH:
  
  • No restriction stated
• RFL:
  
  • Non-formulary
• RNOH:
  
  • Non-formulary
• UCLH:
• WH:
  
  • Non-formulary

 (hospital only prescribing) for renal transplant

for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

Provider notes

• NMUH:
  
  • No restriction stated
• RFL:
  
  • Non-formulary
• RNOH:
  
  • Non-formulary
• UCLH:
• WH:
  
  • Non-formulary

 (hospital only prescribing) for renal transplant

for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

Provider notes

• NMUH:
  
  
  • No restriction stated
• RFL:
  
  
  • Liver transplant: Preferred brand for new patients
  • Renal transplant: Not for new patients
  • Transplant patients must be maintained on the same brand
• RNOH:
  
  
  • Non-formulary
• UCLH:
• WH:
  
  
  • Non-formulary

 (hospital only prescribing) for renal transplant

for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

Provider notes

• NMUH:
  
  
  • Restricted to Consultant use only.
• RFL:
  
  
  • Liver transplant: Not for new patients unless liquid formulation required
  • Renal transplant: Preferred brand for renal transplant
  • Transplant patients must be maintained on the same brand
• RNOH:
  
  
  • Non-formulary
• UCLH:
• WH:
  
  
  • Non-formulary

 (hospital only prescribing) for renal transplant

for other transplants

NOTE: There is more than one monograph for Ciclosporin, click here to search for formulary status and its use for other indications. 

Provider notes

• NMUH:
  
  
  • No restriction stated
• RFL:
  
  
  • Liver transplant: Not for new patients
  • Renal transplant: Not for new patients
  • Transplant patients must be maintained on the same brand
• RNOH:
  
  
  • Non-formulary
• UCLH:
• WH:
  
  
  • Non-formulary

 (hospital only prescribing) for all new transplants, except liver

 for existing transplants and liver transplants

See NICE TA for eligibility criteria

Provider notes

• NMUH:
  
  
  • See links below
  • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
  
  
  • Approved for renal and liver transplants
• RNOH:
  
  
  • Non-formulary
• UCLH:
• WH:
  
  
  • Non-formulary

 (hospital only prescribing) for all new transplants, except liver

 for existing transplants and liver transplants

Provider notes

• NMUH:
  
  • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
  
  
  • Liver transplant: Preferred brand for new patients
  • Kidney transplant: Preferred brand for patients
  • Transplant patients must be maintained on the same brand
• RNOH:
  
  
  • Non-formulary
• UCLH:
• WH:
  
  
  • Non-formulary

  For all new transplants, except liver

  Existing transplants and liver transplants

Provider notes

• NMUH:
  
  • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
  
  • Non-formulary
• RNOH:
  
  • Non-formulary
• UCLH:
• WH:
  
  • Non-formulary

  For all new transplants, except liver

  Existing transplants and liver transplants

Provider notes

• NMUH:
  
  • No restriction stated
• RFL:
  
  • Historic transplant patients
  • Transplant patients must be maintained on the same brand
• RNOH:
  
  • Non-formulary
• UCLH:
• WH:
  
  • Non-formulary

  For all new transplants, except liver

  Existing transplants and liver transplants

Provider notes

• NMUH:
  
  • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
  
  • Non-formulary
• RNOH:
  
  • Non-formulary
• UCLH:
• WH:
  
  • Non-formulary

  For all new transplants, except liver

  Existing transplants and liver transplants

Provider notes

• NMUH:
  • Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
  • Historic transplant patients
  • Transplant patients must be maintained on the same brand
• RNOH:
  • Non-formulary
• UCLH:
• WH:
  • Non-formulary

  For all new transplants, except liver

  Existing transplants and liver transplants

Provider notes

• NMUH:
• Not to be intiated at NMUH. For continuation of immunosuppressant therapy
• RFL:
• Approved for immunosuppression in liver and renal transplants for patient in whom once-daily tacrolimus is indicated. For RFL only (approved by DTC in May-16, ratified by JFC in June-16)
• RNOH:
• Non-formulary
• UCLH:
• WH:
• Non-formulary